|

Pembrolizumab infusion Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Checkpoint blockade administration, Keytruda

Pipeline

Early 1: 1Phase 1/2: 1

Top Sponsors

  • Abramson Cancer Center at Penn Medicine2

Indications

  • Cancer2
  • Renal Cell Carcinoma1
  • Breast Cancer1

Philadelphia, Pennsylvania2 trials

BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy

Perelman Center for Advanced Medicine

Phase 1/2
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Abramson Cancer Center at University of Pennsylvania

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.